Discussion Topic: Class 1C Antiarrhythmics for Premature Ventricular Complex Suppression in Nonischemic Cardiomyopathy With Implantable Cardioverter-Defibrillators
William H. Sauer, MD, FHRS, CCDS, Brigham and Women’s Hospital is joined by Edward P. Gerstenfeld, MD, MS, FHRS, University of California, San Francisco, and Yasser Rodriguez, MBA, MD, Cleveland Clinic Florida to discuss premature ventricular complexes (PVCs) are common and associated with worse outcomes in patients with heart failure. Class 1C antiarrhythmic drugs (AADs) effectively suppress PVCs, but guidelines currently restrict their use in structural heart disease.
Host: William Sauer, MD, FHRS, CCDS
Guests: Edward Gerstenfeld, MD, MS, FHRS & Yasser Rodriguez, MBA, MD
Speaker and Article Information: Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources

Podcasts
The Lead Episode 100: A Discussion of Subcutaneous Implantable Defibrillators in Young Patients
April 18, 2025

Podcasts
The Lead Episode 99: A Discussion of Artificial Intelligence for Individualized Treatment of Persistent Atrial Fibrillation
April 15, 2025

Podcasts
The Lead Episode 98: A Discussion of Effect of Target Education of Patients with Atrial Fibrillation on Unplanned Cardiovascular Outcomes
April 4, 2025